Pharmaceutical Technology1 天
Utidelone by BioStar Pharmaceuticals for Ovarian Cancer: Likelihood of Approval
Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase I for Ovarian Cancer.
Pharmaceutical Technology1 天
Utidelone by BioStar Pharmaceuticals for Soft Tissue Sarcoma: Likelihood of Approval
Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase I for Soft Tissue Sarcoma.